Safety and Pharmacokinetics of Recombinant Factor XIII in Patients With Congenital Factor Xlll Deficiency
Completed · Phase 1
Conditions studied: Congenital Bleeding Disorder, Congenital FXIII Deficiency
In brief
This trial was conducted in the United States of America (USA). The aim of this trial was to investigate safety and pharmacokinetics of escalating single doses of catridecacog (recombinant factor XIII, rFXIII) in patients with congenital factor XIII deficiency.
Key facts
- Study ID
- NCT00056589
- Run by
- Novo Nordisk A/S
- People needed
- 11
- Starts
- 2003-03-01
- Expected to finish
- 2003-10-01
- Last updated by the study team
- 2017-01-11
Who can join
Age: 18 and older. Sex: any. Healthy volunteers: not accepted.
You may qualify if…
- Documental congenital FXIII deficiency
- Normal platelet count and clotting parameters
- Adequate renal and hepatic function
- If female and of child-bearing potential, negative serum pregnancy test within 7 days of enrollment
- If a sexually active male or a sexually active female of child-bearing potential, agreement to use a medically accepted form of contraception from the time of enrollment to completion of all follow-up study visits
- Negative drug and alcohol screens
You may not qualify if…
- Received blood products or FXIII concentrates within 4 weeks of study enrollment
- Known antibodies to FXIII
- Hereditary or acquired coagulation disorder other than FXIII deficiency
- Previous history of autoimmune disorders involving autoantibodies e.g., systemic lupus erythematosus
- Previous history of thromboembolic events e.g., cerebrovascular accident or deep vein thrombosis or administration of any antithrombotic or antiplatelet drugs within 7 days of study enrollment
- Received treatment with any experimental agent within 30 days of study enrollment
- Any surgical procedure in the 30 days prior to enrollment
- Donated blood within 30 days prior to enrollment
Where it is running
- Novo Nordisk Investigational Site — Los Angeles, California, United States
Full record on ClinicalTrials.gov
Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.